Liminal Biosciences Confirms Receipt of Unsolicited Non-Binding Transaction Proposal

LAVAL, QC and CAMBRIDGE, England, April 5, 2023 /PRNewswire/ – Liminal BioSciences Inc. (NASDAQ: LMNL) (“Liminal BioSciences” or the “Company”), confirms that following close of markets on April 4, 2023, the Board of Directors of the Company (the “Board”) received a non-binding proposal…